Welcome to the autism issue! We interviewed Dr. Serena Wieder on evidence-based developmental approaches for kids with ASD, ones that bring the humanity back into autism treatment by returning our focus to the nurturing relationships between parents and children, building on children’s ideas to improve communication and learning.
Read More
It’s a vexing question: At what point do you consider prescribing antipsychotics for aggressive children? The potential side effects—weight gain, sedation, possible movement side effects, and metabolic abnormalities—encourage us to think long and hard about this, and there are few good evidence-based guidelines.
Read More
When I think of a child with autism, I want to discover who he is—not just his diagnosis, but how he relates, feels, functions, and learns in the context of family, culture, environment, and education.
Read More
ACT seeks to teach us to mindfully observe our internal and external experiences and to increase our willingness to experience things, which may either be out of our control or otherwise necessary to honor our core values.
Read More
Disorders of lipid metabolism—specifically inefficient metabolism of lipids—have been implicated as part of the metabolic complexity in children with autism spectrum disorder. Research points to the neuroprotective effects of simvastatin over other statins, due to its greater ability to cross the blood-brain barrier. But does that neuroprotection translate to differences in behavior?
Read More
The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 2 CME credits.
Read More
Dr. Joshua Feder studied mathematics and medicine at Boston University, Psychiatry at Naval Regional Medical Center San Diego, serving the first Gulf War in child and adolescent psychiatry fellowship at Tripler Army Medical Center in Honolulu, and eventually became Chief of Child Psychiatry at the National Naval Medical Center in Bethesda, MD. Dr. Feder now practices in Solana Beach, California, and serves as Executive Medical Director at Positive Development, providing relationship-based support for families, with research at UCSD, SDSU, Fielding Graduate University, An Najah National University, Quicksilver Software, Autism Is inclusion program, and Programmatic Lead for the International Networking Group on Peace Building with Young Children, with projects in the US, Northern Ireland, and the Middle East. Dr. Feder co-authored the first American Academy of Child & Adolescent Psychiatry Practice Parameter on Autism and serves as Co-Chair of the Disaster & Trauma Committee at AACAP. Dr Feder was founding policy chair for the California Association for Infant Mental Health and advocates worldwide on access to care, climate policy, and peacebuilding. His recent books include Child Medication Fact Book for Psychiatric Practice, Second Edition (2023) and Prescribing Psychotropics (2021).
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
